IPCA Laboratories rose 1.2% to Rs 1262.9 after the company announced decent Q3 earnings during market hours today, 12 February 2020.
On a consolidated basis, IPCA Laboratories' net profit jumped 24.13% to Rs 197.61 crore in Q3 December 2019 as against 159.19 crore posted in Q3 December 2018. Revenue from operations rose 21% year-on-year (YoY) to Rs 1212.86 crore in Q3 December 2019.Profit before tax (PBT) during the quarter stood at Rs 234.43 crore, up by 19.28% from Rs 196.53 crore reported in Q3 December 2018. Tax expense declined 1% year-on-year (YoY) to Rs 36.89 crore in Q3 December 2019.
EBITDA (before forex) jumped 37% to Rs 290.03 crore in Q3 December 2019 as compared to Rs 211.26 crore posted in Q3 December 2018. EBITDA margin grew to 23.56% in Q3 December 2019 from 20.72% recorded in Q3 December 2018.
Indian formulations income stood at Rs 485.63 crore, rising 15% YoY. Exports income surged 25% YoY to Rs 585.61 crore in Q3 December 2019.
The company has declared a dividend of Rs 5 per equity share and set a record date on 20 February 2020.
IPCA Laboratories is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app